NeuroSense Therapeutics L...
1.02
-0.01 (-0.97%)
At close: Jan 15, 2025, 1:38 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -1.06 -1.25 -1.91 -2.77 -6.39
PS Ratio n/a n/a n/a n/a n/a
PB Ratio -5.71 2.50 0.53 11.90 8.54
P/FCF Ratio -1.26 -1.83 -3.07 -11.14 -13.31
P/OCF Ratio -1.27 -1.85 -3.1 -11.28 -13.47
OCF/S Ratio n/a n/a n/a n/a n/a
Debt / Equity Ratio -0.08 0.04 0.20 n/a n/a
Quick Ratio 0.84 6.41 19.41 6.08 24.68
Current Ratio 0.84 4.28 19.12 6.08 24.68
Asset Turnover n/a n/a n/a n/a n/a
Interest Coverage -21.91 -903.47 -4.84 -2.89K -247
Return on Equity (ROE) 5.39 -1.99 -0.28 -4.29 -1.34
Return on Assets (ROA) -3.18 -1.45 -0.22 -3.63 -1.28
Return on Capital (ROIC) 42.58 -2.26 -0.52 -4.38 -1.35
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a